Effect of Cilostazol on Patients With Diabetes Who Underwent Endovascular Treatment for Peripheral Artery Disease

Background No large‐scale study has compared the clinical impact of triple antiplatelet therapy (TAPT: aspirin, clopidogrel, and cilostazol) and dual antiplatelet therapy (DAPT) on adverse limb events in patients with diabetes after endovascular therapy (EVT) for peripheral artery disease. Thus, we...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Jung‐Joon Cha, Jae Young Cho, Subin Lim, Ju Hyeon Kim, Hyung Joon Joo, Jae Hyoung Park, Soon Jun Hong, Do‐Sun Lim, Hyungdon Kook, Seung Hun Lee, Young‐Guk Ko, Pil‐Ki Min, Jae‐Hwan Lee, Chang‐Hwan Yoon, In‐Ho Chae, Seung Whan Lee, Sang‐Rok Lee, Seung Hyuk Choi, Yoon Seok Koh, Cheol Woong Yu
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2023-06-01
Edice:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Témata:	cilostazol critical limb ischemia diabetes peripheral artery disease triple antiplatelet therapy
On-line přístup:	https://www.ahajournals.org/doi/10.1161/JAHA.122.027334
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!